↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$333KSold on the market
1Companies
Sep 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202617:02 | Sep 11, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Commercial Officer | F · Tax | $156.22 | −3,386 | 67,297 | -5% | $529K | ||
| Sep 15, 202617:02 | Sep 11, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Commercial Officer | A · Grant | — | +6,275 | 70,683 | +10% | — | ||
| Sep 10, 202620:29 | Sep 9, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Commercial Officer | S · Sell10b5-1 | $154.61 | −2,154 | 64,408 | -3% | −$333K | ||
| Sep 10, 202620:29 | Sep 9, 2026 | NBIXNEUROCRINE BIOSCIENCES INC | Chief Commercial Officer | M · Exercise10b5-1 | $43.24 | +3,194 | 66,562 | +5% | $138K |